211 related articles for article (PubMed ID: 31448551)
1. Prevalence of hypertension and cardiovascular risk factors among long-term AIDS survivors: A report from the field.
Pierre S; Seo G; Rivera VR; Walsh KF; Victor JJ; Charles B; Julmiste G; Dumont E; Apollon A; Cadet M; Saint-Vil A; Marcelin A; Severe P; Lee MH; Kingery J; Koenig S; Fitzgerald D; Pape J; McNairy ML
J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1558-1566. PubMed ID: 31448551
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure and mortality in a prospective cohort of HIV-infected adults in Port-au-Prince, Haiti.
Batavia AS; Severe P; Lee MH; Apollon A; Zhu YS; Dupnik KM; McNairy ML; Pape JW; Fitzgerald DW; Peck RN
J Hypertens; 2018 Jul; 36(7):1533-1539. PubMed ID: 29634661
[TBL] [Abstract][Full Text] [Related]
3. Integrating hypertension services at an HIV clinic in Port-au-Prince, Haiti: A report from the field.
Walsh KF; Lee MH; Martelly S; Pierre MM; Joseph J; Gustin M; Peck RN; Fitzgerald DW; Pape JW; McNairy M
J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1485-1492. PubMed ID: 30259642
[TBL] [Abstract][Full Text] [Related]
4. Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study.
Diaz CM; Segura ER; Luz PM; Clark JL; Ribeiro SR; De Boni R; Eksterman L; Moreira R; Currier JS; Veloso VG; Grinsztejn B; Lake JE
BMC Infect Dis; 2016 Aug; 16():376. PubMed ID: 27503230
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease.
Guo F; Hsieh E; Lv W; Han Y; Xie J; Li Y; Song X; Li T
BMC Infect Dis; 2017 Apr; 17(1):287. PubMed ID: 28427339
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-sectional study.
Ekrikpo UE; Akpan EE; Ekott JU; Bello AK; Okpechi IG; Kengne AP
BMJ Open; 2018 Jul; 8(7):e019664. PubMed ID: 30030310
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.
Amadi C; Lawal F; Ajiboye W; Agbim R; Mbakwem A; Ajuluchukwu J; Oke DA
Int J Clin Pharm; 2020 Dec; 42(6):1469-1479. PubMed ID: 32960427
[TBL] [Abstract][Full Text] [Related]
8. Subclinical atherosclerosis and associated risk factors among HIV-infected adults in Jos, North Central Nigeria: a cross-sectional study.
Imoh LC; Ani CC; Iyua KO; Odo AI; Amusa GA; Osaigbovo GO; Isichei CO; Agbaji OO; Imade G; Zoakah AI; Okeahialam BN; Sagay AS
Pan Afr Med J; 2020; 37():388. PubMed ID: 33796201
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors among ART-experienced people with HIV in South Africa.
Hyle EP; Bekker LG; Martey EB; Huang M; Xu A; Parker RA; Walensky RP; Middelkoop K
J Int AIDS Soc; 2019 Apr; 22(4):e25274. PubMed ID: 30990252
[TBL] [Abstract][Full Text] [Related]
10. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services.
Divala OH; Amberbir A; Ismail Z; Beyene T; Garone D; Pfaff C; Singano V; Akello H; Joshua M; Nyirenda MJ; Matengeni A; Berman J; Mallewa J; Chinomba GS; Kayange N; Allain TJ; Chan AK; Sodhi SK; van Oosterhout JJ
BMC Public Health; 2016 Dec; 16(1):1243. PubMed ID: 27955664
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk factors among people living with HIV in rural Kenya: a clinic-based study.
Juma K; Nyabera R; Mbugua S; Odinya G; Jowi J; Ngunga M; Zakus D; Yonga G
Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):52-56. PubMed ID: 30720846
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy in a thousand patients with AIDS in Haiti.
Severe P; Leger P; Charles M; Noel F; Bonhomme G; Bois G; George E; Kenel-Pierre S; Wright PF; Gulick R; Johnson WD; Pape JW; Fitzgerald DW
N Engl J Med; 2005 Dec; 353(22):2325-34. PubMed ID: 16319381
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study.
Agu CE; Uchendu IK; Nsonwu AC; Okwuosa CN; Achukwu PU
BMC Public Health; 2019 Aug; 19(1):1143. PubMed ID: 31429736
[TBL] [Abstract][Full Text] [Related]
14. Hypertension among people living with HIV/AIDS in Cameroon: A cross-sectional analysis from Central Africa International Epidemiology Databases to Evaluate AIDS.
Dzudie A; Hoover D; Kim HY; Ajeh R; Adedimeji A; Shi Q; Pefura Yone W; Nsame Nforniwe D; Thompson Njie K; Pascal Kengne A; Ebasone PV; Barche B; Bissek Anne Cecile ZK; Nash D; Yotebieng M; Anastos K
PLoS One; 2021; 16(7):e0253742. PubMed ID: 34292956
[TBL] [Abstract][Full Text] [Related]
15. High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi.
Mathabire Rücker SC; Tayea A; Bitilinyu-Bangoh J; Bermúdez-Aza EH; Salumu L; Quiles IA; Szumilin E; Chirwa Z; Rick F; Maman D
AIDS; 2018 Jan; 32(2):253-260. PubMed ID: 29135581
[TBL] [Abstract][Full Text] [Related]
16. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.
Grinsztejn B; Hosseinipour MC; Ribaudo HJ; Swindells S; Eron J; Chen YQ; Wang L; Ou SS; Anderson M; McCauley M; Gamble T; Kumarasamy N; Hakim JG; Kumwenda J; Pilotto JH; Godbole SV; Chariyalertsak S; de Melo MG; Mayer KH; Eshleman SH; Piwowar-Manning E; Makhema J; Mills LA; Panchia R; Sanne I; Gallant J; Hoffman I; Taha TE; Nielsen-Saines K; Celentano D; Essex M; Havlir D; Cohen MS;
Lancet Infect Dis; 2014 Apr; 14(4):281-90. PubMed ID: 24602844
[TBL] [Abstract][Full Text] [Related]
17. Hypertension and traditional risk factors for cardiovascular diseases among treatment naïve HIV- infected adults initiating antiretroviral therapy in Urban Tanzania.
Mwakyandile TM; Shayo GA; Sasi PG; Mugusi FM; Barabona G; Ueno T; Lyamuya EF
BMC Cardiovasc Disord; 2023 Jun; 23(1):309. PubMed ID: 37340390
[TBL] [Abstract][Full Text] [Related]
18. AIDS diarrhea and antiretroviral drug concentrations: a matched-pair cohort study in Port au Prince, Haiti.
Dillingham R; Leger P; Beauharnais CA; Miller E; Kashuba A; Jennings S; Dupnik K; Samie A; Eyma E; Guerrant R; Pape J; Fitzgerald D
Am J Trop Med Hyg; 2011 Jun; 84(6):878-82. PubMed ID: 21633022
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.
Bastard JP; Couffignal C; Fellahi S; Bard JM; Mentre F; Salmon D; Katlama C; Raffi F; Leport C; Capeau J;
Diabetes Metab; 2019 Dec; 45(6):573-581. PubMed ID: 30862472
[TBL] [Abstract][Full Text] [Related]
20. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
